Protocol Summaries: GSK1827771
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| 110394 | Phase 1 | A Phase I, Randomized, Observer- and Subject-Blind, Placebo-Controlled, Single Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1827771 in Healthy Volunteers | Completed |